Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02148588 · ClinicalTrials.gov registry record · NA
Peripheral Sensory Input in Central Post Stroke Pain (CPSP)
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02148588 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 8 participants.
The verdict
NCT02148588, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Prospective, open-label study in 10 patients with Central Post Stroke Pain (CPSP). The study will evaluate the effects of peripheral nerve blockade on spontaneous pain and evoked thermal and mechanical responses in CPSP, and assesses the associated local anesthetic pharmacokinetics.
Interventions
- DRUG Ultrasound-guided peripheral nerve block with 2% lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-01-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02148588
The ClinicalTrials.gov registry entry for NCT02148588 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound-guided peripheral nerve block with 2% lidocaine is the first listed.
NCT02148588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02148588 about?
NCT02148588 is a clinical study titled "Peripheral Sensory Input in Central Post Stroke Pain (CPSP)". Prospective, open-label study in 10 patients with Central Post Stroke Pain (CPSP). The study will evaluate the effects of peripheral nerve blockade on spontaneous pain and evoked thermal and mechanical responses in CPSP, and assesses the associated local anesthetic pharmacokinetics.
What is the current status of trial NCT02148588?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2014-08. Estimated completion is 2017-01-25.
What interventions are being tested in trial NCT02148588?
The interventions under investigation include: Ultrasound-guided peripheral nerve block with 2% lidocaine (DRUG).
Who is sponsoring clinical trial NCT02148588?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.